SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXA6
|
ENSG00000106006.6 | homeobox A6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA6 | hg19_v2_chr7_-_27187393_27187393 | 0.76 | 1.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_27179814 | 5.77 |
ENST00000522788.1
ENST00000521779.1 |
HOXA3
|
homeobox A3 |
chr11_-_117695449 | 5.44 |
ENST00000292079.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
chr17_-_46671323 | 5.33 |
ENST00000239151.5
|
HOXB5
|
homeobox B5 |
chr4_+_41258786 | 5.10 |
ENST00000503431.1
ENST00000284440.4 ENST00000508768.1 ENST00000512788.1 |
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
chr5_+_174151536 | 4.87 |
ENST00000239243.6
ENST00000507785.1 |
MSX2
|
msh homeobox 2 |
chr17_+_42634844 | 4.86 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
chr7_-_27142290 | 4.77 |
ENST00000222718.5
|
HOXA2
|
homeobox A2 |
chr9_-_123812542 | 4.32 |
ENST00000223642.1
|
C5
|
complement component 5 |
chr14_-_95236551 | 4.21 |
ENST00000238558.3
|
GSC
|
goosecoid homeobox |
chr17_-_46688334 | 4.19 |
ENST00000239165.7
|
HOXB7
|
homeobox B7 |
chr2_-_25451065 | 4.17 |
ENST00000606328.1
|
RP11-458N5.1
|
RP11-458N5.1 |
chr17_-_46692287 | 4.01 |
ENST00000239144.4
|
HOXB8
|
homeobox B8 |
chr6_+_136172820 | 4.00 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chr17_-_46682321 | 3.80 |
ENST00000225648.3
ENST00000484302.2 |
HOXB6
|
homeobox B6 |
chr20_+_5987890 | 3.65 |
ENST00000378868.4
|
CRLS1
|
cardiolipin synthase 1 |
chr4_+_129730779 | 3.64 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr7_-_27183263 | 3.63 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr17_-_47045949 | 3.63 |
ENST00000357424.2
|
GIP
|
gastric inhibitory polypeptide |
chr6_+_105404899 | 3.54 |
ENST00000345080.4
|
LIN28B
|
lin-28 homolog B (C. elegans) |
chr4_+_129730947 | 3.53 |
ENST00000452328.2
ENST00000504089.1 |
PHF17
|
jade family PHD finger 1 |
chr12_-_122240792 | 3.41 |
ENST00000545885.1
ENST00000542933.1 ENST00000428029.2 ENST00000541694.1 ENST00000536662.1 ENST00000535643.1 ENST00000541657.1 |
AC084018.1
RHOF
|
AC084018.1 ras homolog family member F (in filopodia) |
chr14_-_54423529 | 3.37 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
chr12_-_12674032 | 3.32 |
ENST00000298573.4
|
DUSP16
|
dual specificity phosphatase 16 |
chr8_-_95449155 | 3.28 |
ENST00000481490.2
|
FSBP
|
fibrinogen silencer binding protein |
chr5_-_58882219 | 3.27 |
ENST00000505453.1
ENST00000360047.5 |
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr11_-_115127611 | 3.17 |
ENST00000545094.1
|
CADM1
|
cell adhesion molecule 1 |
chr11_+_123396528 | 3.16 |
ENST00000322282.7
ENST00000529750.1 |
GRAMD1B
|
GRAM domain containing 1B |
chr11_-_8290263 | 3.13 |
ENST00000428101.2
|
LMO1
|
LIM domain only 1 (rhombotin 1) |
chr14_-_54418598 | 3.10 |
ENST00000609748.1
ENST00000558961.1 |
BMP4
|
bone morphogenetic protein 4 |
chr4_+_41614909 | 2.93 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr4_+_129730839 | 2.76 |
ENST00000511647.1
|
PHF17
|
jade family PHD finger 1 |
chr11_-_8285405 | 2.72 |
ENST00000335790.3
ENST00000534484.1 |
LMO1
|
LIM domain only 1 (rhombotin 1) |
chr3_-_157824292 | 2.69 |
ENST00000483851.2
|
SHOX2
|
short stature homeobox 2 |
chr7_+_66800928 | 2.66 |
ENST00000430244.1
|
RP11-166O4.5
|
RP11-166O4.5 |
chr10_-_10504285 | 2.49 |
ENST00000602311.1
|
RP11-271F18.4
|
RP11-271F18.4 |
chr15_-_54025300 | 2.47 |
ENST00000559418.1
|
WDR72
|
WD repeat domain 72 |
chr4_+_129731074 | 2.47 |
ENST00000512960.1
ENST00000503785.1 ENST00000514740.1 |
PHF17
|
jade family PHD finger 1 |
chr11_+_123396307 | 2.46 |
ENST00000456860.2
|
GRAMD1B
|
GRAM domain containing 1B |
chr20_-_50419055 | 2.30 |
ENST00000217086.4
|
SALL4
|
spalt-like transcription factor 4 |
chr13_-_67802549 | 2.29 |
ENST00000328454.5
ENST00000377865.2 |
PCDH9
|
protocadherin 9 |
chr15_-_77988485 | 2.29 |
ENST00000561030.1
|
LINGO1
|
leucine rich repeat and Ig domain containing 1 |
chr14_-_37051798 | 2.28 |
ENST00000258829.5
|
NKX2-8
|
NK2 homeobox 8 |
chr10_-_21806759 | 2.26 |
ENST00000444772.3
|
SKIDA1
|
SKI/DACH domain containing 1 |
chr1_+_6105974 | 2.25 |
ENST00000378083.3
|
KCNAB2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr17_+_79369249 | 2.17 |
ENST00000574717.2
|
RP11-1055B8.6
|
Uncharacterized protein |
chr1_-_91317072 | 2.13 |
ENST00000435649.2
ENST00000443802.1 |
RP4-665J23.1
|
RP4-665J23.1 |
chr2_+_176987088 | 2.08 |
ENST00000249499.6
|
HOXD9
|
homeobox D9 |
chr6_-_85474219 | 2.06 |
ENST00000369663.5
|
TBX18
|
T-box 18 |
chr5_-_59783882 | 1.98 |
ENST00000505507.2
ENST00000502484.2 |
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr17_-_46716647 | 1.95 |
ENST00000608940.1
|
RP11-357H14.17
|
RP11-357H14.17 |
chr10_-_21786179 | 1.94 |
ENST00000377113.5
|
CASC10
|
cancer susceptibility candidate 10 |
chr12_-_102591604 | 1.90 |
ENST00000329406.4
|
PMCH
|
pro-melanin-concentrating hormone |
chr1_+_186265399 | 1.90 |
ENST00000367486.3
ENST00000367484.3 ENST00000533951.1 ENST00000367482.4 ENST00000367483.4 ENST00000367485.4 ENST00000445192.2 |
PRG4
|
proteoglycan 4 |
chr4_+_41614720 | 1.89 |
ENST00000509277.1
|
LIMCH1
|
LIM and calponin homology domains 1 |
chr12_-_14133053 | 1.88 |
ENST00000609686.1
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
chr6_+_100054606 | 1.85 |
ENST00000369215.4
|
PRDM13
|
PR domain containing 13 |
chr2_-_177502659 | 1.84 |
ENST00000295549.4
|
AC017048.3
|
long intergenic non-protein coding RNA 1116 |
chr15_-_56209306 | 1.82 |
ENST00000506154.1
ENST00000338963.2 ENST00000508342.1 |
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
chr16_+_89334512 | 1.81 |
ENST00000602042.1
|
AC137932.1
|
AC137932.1 |
chr2_-_175711133 | 1.72 |
ENST00000409597.1
ENST00000413882.1 |
CHN1
|
chimerin 1 |
chr18_+_20714525 | 1.69 |
ENST00000400473.2
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1 |
chr5_-_58295712 | 1.68 |
ENST00000317118.8
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr10_+_115312766 | 1.66 |
ENST00000351270.3
|
HABP2
|
hyaluronan binding protein 2 |
chr1_+_244214577 | 1.62 |
ENST00000358704.4
|
ZBTB18
|
zinc finger and BTB domain containing 18 |
chr2_-_145278475 | 1.58 |
ENST00000558170.2
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr17_+_39846114 | 1.57 |
ENST00000586699.1
|
EIF1
|
eukaryotic translation initiation factor 1 |
chr7_-_14026123 | 1.55 |
ENST00000420159.2
ENST00000399357.3 ENST00000403527.1 |
ETV1
|
ets variant 1 |
chr2_+_173955327 | 1.51 |
ENST00000422149.1
|
MLTK
|
Mitogen-activated protein kinase kinase kinase MLT |
chr6_+_111195973 | 1.47 |
ENST00000368885.3
ENST00000368882.3 ENST00000451850.2 ENST00000368877.5 |
AMD1
|
adenosylmethionine decarboxylase 1 |
chr11_-_27723158 | 1.47 |
ENST00000395980.2
|
BDNF
|
brain-derived neurotrophic factor |
chr2_+_171571827 | 1.46 |
ENST00000375281.3
|
SP5
|
Sp5 transcription factor |
chr14_-_92413727 | 1.44 |
ENST00000267620.10
|
FBLN5
|
fibulin 5 |
chr1_+_170632250 | 1.40 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
chr4_-_41884620 | 1.38 |
ENST00000504870.1
|
LINC00682
|
long intergenic non-protein coding RNA 682 |
chr4_-_40516560 | 1.35 |
ENST00000513473.1
|
RBM47
|
RNA binding motif protein 47 |
chr2_+_177015950 | 1.34 |
ENST00000306324.3
|
HOXD4
|
homeobox D4 |
chr8_-_25281747 | 1.29 |
ENST00000421054.2
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
chr14_-_92413353 | 1.25 |
ENST00000556154.1
|
FBLN5
|
fibulin 5 |
chr12_-_16761007 | 1.25 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr10_-_92681033 | 1.25 |
ENST00000371697.3
|
ANKRD1
|
ankyrin repeat domain 1 (cardiac muscle) |
chr20_-_50418972 | 1.24 |
ENST00000395997.3
|
SALL4
|
spalt-like transcription factor 4 |
chr7_+_114055052 | 1.23 |
ENST00000462331.1
ENST00000408937.3 ENST00000403559.4 ENST00000350908.4 ENST00000393498.2 ENST00000393495.3 ENST00000378237.3 ENST00000393489.3 |
FOXP2
|
forkhead box P2 |
chr10_-_33623310 | 1.23 |
ENST00000395995.1
ENST00000374823.5 ENST00000374821.5 ENST00000374816.3 |
NRP1
|
neuropilin 1 |
chr20_-_50418947 | 1.22 |
ENST00000371539.3
|
SALL4
|
spalt-like transcription factor 4 |
chrX_+_9431324 | 1.22 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr16_-_51185149 | 1.21 |
ENST00000566102.1
ENST00000541611.1 |
SALL1
|
spalt-like transcription factor 1 |
chr7_+_28452130 | 1.16 |
ENST00000357727.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr1_+_41174988 | 1.13 |
ENST00000372652.1
|
NFYC
|
nuclear transcription factor Y, gamma |
chr7_+_142374104 | 1.11 |
ENST00000604952.1
|
MTRNR2L6
|
MT-RNR2-like 6 |
chr17_-_56082455 | 1.11 |
ENST00000578794.1
|
RP11-159D12.5
|
Uncharacterized protein |
chr7_+_129015671 | 1.06 |
ENST00000466993.1
|
AHCYL2
|
adenosylhomocysteinase-like 2 |
chr6_-_9933500 | 1.05 |
ENST00000492169.1
|
OFCC1
|
orofacial cleft 1 candidate 1 |
chr7_-_27205136 | 1.04 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
chr10_-_118897567 | 1.03 |
ENST00000369206.5
|
VAX1
|
ventral anterior homeobox 1 |
chr16_-_51185172 | 1.01 |
ENST00000251020.4
|
SALL1
|
spalt-like transcription factor 1 |
chrX_-_19688475 | 0.99 |
ENST00000541422.1
|
SH3KBP1
|
SH3-domain kinase binding protein 1 |
chr20_+_62795827 | 0.98 |
ENST00000328439.1
ENST00000536311.1 |
MYT1
|
myelin transcription factor 1 |
chr11_+_20620946 | 0.98 |
ENST00000525748.1
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5 |
chr2_+_66918558 | 0.98 |
ENST00000435389.1
ENST00000428590.1 ENST00000412944.1 |
AC007392.3
|
AC007392.3 |
chr3_-_114477787 | 0.97 |
ENST00000464560.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr8_+_9953214 | 0.95 |
ENST00000382490.5
|
MSRA
|
methionine sulfoxide reductase A |
chr2_-_145277569 | 0.95 |
ENST00000303660.4
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr10_-_118897806 | 0.94 |
ENST00000277905.2
|
VAX1
|
ventral anterior homeobox 1 |
chrX_+_28605516 | 0.93 |
ENST00000378993.1
|
IL1RAPL1
|
interleukin 1 receptor accessory protein-like 1 |
chr18_+_28956740 | 0.92 |
ENST00000308128.4
ENST00000359747.4 |
DSG4
|
desmoglein 4 |
chr7_-_14026063 | 0.92 |
ENST00000443608.1
ENST00000438956.1 |
ETV1
|
ets variant 1 |
chr4_-_111563076 | 0.91 |
ENST00000354925.2
ENST00000511990.1 |
PITX2
|
paired-like homeodomain 2 |
chr2_-_176948641 | 0.90 |
ENST00000308618.4
|
EVX2
|
even-skipped homeobox 2 |
chr3_-_27764190 | 0.88 |
ENST00000537516.1
|
EOMES
|
eomesodermin |
chr8_+_9953061 | 0.88 |
ENST00000522907.1
ENST00000528246.1 |
MSRA
|
methionine sulfoxide reductase A |
chr1_+_167298281 | 0.86 |
ENST00000367862.5
|
POU2F1
|
POU class 2 homeobox 1 |
chr8_-_80993010 | 0.80 |
ENST00000537855.1
ENST00000520527.1 ENST00000517427.1 ENST00000448733.2 ENST00000379097.3 |
TPD52
|
tumor protein D52 |
chr13_+_36050881 | 0.78 |
ENST00000537702.1
|
NBEA
|
neurobeachin |
chr10_-_77161533 | 0.77 |
ENST00000535216.1
|
ZNF503
|
zinc finger protein 503 |
chr20_+_11898507 | 0.74 |
ENST00000378226.2
|
BTBD3
|
BTB (POZ) domain containing 3 |
chr6_+_108487245 | 0.73 |
ENST00000368986.4
|
NR2E1
|
nuclear receptor subfamily 2, group E, member 1 |
chr12_+_41831485 | 0.73 |
ENST00000539469.2
ENST00000298919.7 |
PDZRN4
|
PDZ domain containing ring finger 4 |
chr1_-_216896674 | 0.73 |
ENST00000475275.1
ENST00000469486.1 ENST00000481543.1 |
ESRRG
|
estrogen-related receptor gamma |
chr3_-_114343039 | 0.72 |
ENST00000481632.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr2_-_145188137 | 0.72 |
ENST00000440875.1
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr8_+_92261516 | 0.71 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
chr5_-_27038683 | 0.70 |
ENST00000511822.1
ENST00000231021.4 |
CDH9
|
cadherin 9, type 2 (T1-cadherin) |
chr3_+_69812877 | 0.70 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
chr10_+_115312825 | 0.69 |
ENST00000537906.1
ENST00000541666.1 |
HABP2
|
hyaluronan binding protein 2 |
chr3_-_114477962 | 0.69 |
ENST00000471418.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr2_-_77749474 | 0.67 |
ENST00000409093.1
ENST00000409088.3 |
LRRTM4
|
leucine rich repeat transmembrane neuronal 4 |
chr1_-_216896780 | 0.66 |
ENST00000459955.1
ENST00000366937.1 ENST00000408911.3 ENST00000391890.3 |
ESRRG
|
estrogen-related receptor gamma |
chr2_-_77749387 | 0.66 |
ENST00000409884.1
|
LRRTM4
|
leucine rich repeat transmembrane neuronal 4 |
chr5_-_160973649 | 0.65 |
ENST00000393959.1
ENST00000517547.1 |
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
chr2_-_164592497 | 0.65 |
ENST00000333129.3
ENST00000409634.1 |
FIGN
|
fidgetin |
chr4_-_176733377 | 0.63 |
ENST00000505375.1
|
GPM6A
|
glycoprotein M6A |
chr16_+_86612112 | 0.62 |
ENST00000320241.3
|
FOXL1
|
forkhead box L1 |
chr17_-_46692457 | 0.61 |
ENST00000468443.1
|
HOXB8
|
homeobox B8 |
chr1_-_217250231 | 0.61 |
ENST00000493748.1
ENST00000463665.1 |
ESRRG
|
estrogen-related receptor gamma |
chr2_+_47454054 | 0.60 |
ENST00000426892.1
|
AC106869.2
|
AC106869.2 |
chr12_-_102874416 | 0.60 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr10_-_77161650 | 0.60 |
ENST00000372524.4
|
ZNF503
|
zinc finger protein 503 |
chr4_+_124571409 | 0.60 |
ENST00000514823.1
ENST00000511919.1 ENST00000508111.1 |
RP11-93L9.1
|
long intergenic non-protein coding RNA 1091 |
chr2_-_2334888 | 0.60 |
ENST00000428368.2
ENST00000399161.2 |
MYT1L
|
myelin transcription factor 1-like |
chr3_+_152017181 | 0.60 |
ENST00000498502.1
ENST00000324196.5 ENST00000545754.1 ENST00000357472.3 |
MBNL1
|
muscleblind-like splicing regulator 1 |
chr7_-_5463175 | 0.58 |
ENST00000399537.4
ENST00000430969.1 |
TNRC18
|
trinucleotide repeat containing 18 |
chr12_-_16762971 | 0.58 |
ENST00000540590.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr12_-_24103954 | 0.57 |
ENST00000441133.2
ENST00000545921.1 |
SOX5
|
SRY (sex determining region Y)-box 5 |
chr6_-_10115007 | 0.57 |
ENST00000485268.1
|
OFCC1
|
orofacial cleft 1 candidate 1 |
chr17_-_38911580 | 0.56 |
ENST00000312150.4
|
KRT25
|
keratin 25 |
chr16_+_72459838 | 0.56 |
ENST00000564508.1
|
AC004158.3
|
AC004158.3 |
chr2_-_77749336 | 0.54 |
ENST00000409282.1
|
LRRTM4
|
leucine rich repeat transmembrane neuronal 4 |
chr12_-_109797249 | 0.53 |
ENST00000538041.1
|
RP11-256L11.1
|
RP11-256L11.1 |
chr6_-_22297730 | 0.53 |
ENST00000306482.1
|
PRL
|
prolactin |
chr2_+_162272605 | 0.53 |
ENST00000389554.3
|
TBR1
|
T-box, brain, 1 |
chr6_-_136847610 | 0.52 |
ENST00000454590.1
ENST00000432797.2 |
MAP7
|
microtubule-associated protein 7 |
chr10_-_106240032 | 0.50 |
ENST00000447860.1
|
RP11-127O4.3
|
RP11-127O4.3 |
chr9_-_73483926 | 0.50 |
ENST00000396283.1
ENST00000361823.5 |
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr6_-_46293378 | 0.50 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr12_-_86650045 | 0.49 |
ENST00000604798.1
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr15_+_36994210 | 0.49 |
ENST00000562489.1
|
C15orf41
|
chromosome 15 open reading frame 41 |
chr15_+_80364901 | 0.49 |
ENST00000560228.1
ENST00000559835.1 ENST00000559775.1 ENST00000558688.1 ENST00000560392.1 ENST00000560976.1 ENST00000558272.1 ENST00000558390.1 |
ZFAND6
|
zinc finger, AN1-type domain 6 |
chr12_-_16761117 | 0.48 |
ENST00000538051.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr9_-_20622478 | 0.46 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr4_+_88720698 | 0.46 |
ENST00000226284.5
|
IBSP
|
integrin-binding sialoprotein |
chr8_+_142264664 | 0.46 |
ENST00000518520.1
|
RP11-10J21.3
|
Uncharacterized protein |
chr2_+_102508955 | 0.45 |
ENST00000414004.2
|
FLJ20373
|
FLJ20373 |
chr3_-_114173654 | 0.44 |
ENST00000482689.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr3_+_69928256 | 0.44 |
ENST00000394355.2
|
MITF
|
microphthalmia-associated transcription factor |
chr5_-_38557561 | 0.43 |
ENST00000511561.1
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr17_-_38956205 | 0.43 |
ENST00000306658.7
|
KRT28
|
keratin 28 |
chr18_-_22932080 | 0.43 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
chr9_+_130026756 | 0.42 |
ENST00000314904.5
ENST00000373387.4 |
GARNL3
|
GTPase activating Rap/RanGAP domain-like 3 |
chr3_+_68053359 | 0.42 |
ENST00000478136.1
|
FAM19A1
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 |
chrX_-_124097620 | 0.42 |
ENST00000371130.3
ENST00000422452.2 |
TENM1
|
teneurin transmembrane protein 1 |
chr4_+_96012614 | 0.42 |
ENST00000264568.4
|
BMPR1B
|
bone morphogenetic protein receptor, type IB |
chr5_+_161494770 | 0.42 |
ENST00000414552.2
ENST00000361925.4 |
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
chr17_-_10421853 | 0.42 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
chr1_+_168250194 | 0.41 |
ENST00000367821.3
|
TBX19
|
T-box 19 |
chr18_-_3845321 | 0.41 |
ENST00000539435.1
ENST00000400147.2 |
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr3_+_35721182 | 0.41 |
ENST00000413378.1
ENST00000417925.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr18_-_3845293 | 0.41 |
ENST00000400145.2
|
DLGAP1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr1_+_215179188 | 0.41 |
ENST00000391895.2
|
KCNK2
|
potassium channel, subfamily K, member 2 |
chr9_-_73483958 | 0.40 |
ENST00000377101.1
ENST00000377106.1 ENST00000360823.2 ENST00000377105.1 |
TRPM3
|
transient receptor potential cation channel, subfamily M, member 3 |
chr12_-_91576429 | 0.40 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
chr2_-_77749446 | 0.39 |
ENST00000409911.1
|
LRRTM4
|
leucine rich repeat transmembrane neuronal 4 |
chr8_+_70476088 | 0.39 |
ENST00000525999.1
|
SULF1
|
sulfatase 1 |
chr7_-_29235063 | 0.39 |
ENST00000437527.1
ENST00000455544.1 |
CPVL
|
carboxypeptidase, vitellogenic-like |
chr12_-_117319236 | 0.38 |
ENST00000257572.5
|
HRK
|
harakiri, BCL2 interacting protein (contains only BH3 domain) |
chr8_-_93107443 | 0.37 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr4_+_55095264 | 0.37 |
ENST00000257290.5
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr4_-_111563279 | 0.36 |
ENST00000511837.1
|
PITX2
|
paired-like homeodomain 2 |
chr3_+_35721106 | 0.36 |
ENST00000474696.1
ENST00000412048.1 ENST00000396482.2 ENST00000432682.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
chr2_-_99871570 | 0.36 |
ENST00000333017.2
ENST00000409679.1 ENST00000423306.1 |
LYG2
|
lysozyme G-like 2 |
chr14_-_83262540 | 0.36 |
ENST00000554451.1
|
RP11-11K13.1
|
RP11-11K13.1 |
chr12_-_13248562 | 0.36 |
ENST00000457134.2
ENST00000537302.1 |
GSG1
|
germ cell associated 1 |
chr15_+_69854027 | 0.35 |
ENST00000498938.2
|
RP11-279F6.1
|
RP11-279F6.1 |
chr2_-_163695128 | 0.35 |
ENST00000332142.5
|
KCNH7
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
chr1_-_216596738 | 0.34 |
ENST00000307340.3
ENST00000366943.2 ENST00000366942.3 |
USH2A
|
Usher syndrome 2A (autosomal recessive, mild) |
chr13_-_103053946 | 0.34 |
ENST00000376131.4
|
FGF14
|
fibroblast growth factor 14 |
chr2_+_28618532 | 0.33 |
ENST00000545753.1
|
FOSL2
|
FOS-like antigen 2 |
chr15_+_48051920 | 0.33 |
ENST00000559196.1
|
SEMA6D
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
chr14_-_98444386 | 0.32 |
ENST00000556462.1
ENST00000556138.1 |
C14orf64
|
chromosome 14 open reading frame 64 |
chr3_-_114173530 | 0.32 |
ENST00000470311.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr8_-_72268889 | 0.32 |
ENST00000388742.4
|
EYA1
|
eyes absent homolog 1 (Drosophila) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.7 | 5.1 | GO:0007412 | axon target recognition(GO:0007412) |
1.6 | 4.9 | GO:0051795 | positive regulation of catagen(GO:0051795) activation of meiosis(GO:0090427) |
1.6 | 4.8 | GO:0035284 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
1.5 | 12.2 | GO:0010159 | specification of organ position(GO:0010159) |
0.9 | 3.6 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.8 | 3.3 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.7 | 4.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.7 | 4.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.7 | 6.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.7 | 2.1 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.5 | 3.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.5 | 3.6 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.5 | 1.5 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.4 | 3.7 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.4 | 2.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 1.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 3.2 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.4 | 3.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 1.3 | GO:1990637 | response to prolactin(GO:1990637) |
0.3 | 1.2 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.3 | 1.8 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.3 | 5.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 4.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 4.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 1.3 | GO:0060127 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
0.2 | 2.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.2 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 0.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 3.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 2.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 4.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.2 | 4.6 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 1.8 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 1.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 1.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 2.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 4.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 1.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.5 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.3 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 1.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 4.3 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.6 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 0.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.1 | 1.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.4 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.6 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.4 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.1 | 3.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 2.4 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 2.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.9 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 2.3 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 1.6 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.2 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.7 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 2.0 | GO:0007631 | feeding behavior(GO:0007631) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.5 | GO:0072663 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 4.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 1.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 1.0 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.4 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.4 | GO:0021983 | pituitary gland development(GO:0021983) |
0.0 | 0.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 2.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 2.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 5.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 1.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 2.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 6.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.0 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 2.2 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 5.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.3 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 3.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 4.8 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 2.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 4.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.4 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 0.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 8.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 12.4 | GO:0016604 | nuclear body(GO:0016604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.2 | 3.7 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.5 | 1.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.5 | 1.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 6.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 1.2 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.4 | 8.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 5.4 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 2.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 1.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 6.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 4.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 1.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 2.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 8.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 4.3 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 4.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 4.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 1.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.9 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 2.2 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 5.5 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 2.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 13.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 2.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 3.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 1.9 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 1.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.0 | 0.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0030551 | cyclic nucleotide binding(GO:0030551) cAMP binding(GO:0030552) |
0.0 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 1.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 6.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 3.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 4.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 2.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 2.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 3.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 1.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 3.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 7.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 4.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 4.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 4.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 2.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 2.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 5.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.8 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |